Stage 2
At the completion of the manufacturing facility, SBL will transfer the assembly of OraLine IV for the China market to SiYi and in return SBL will receive fifteen percent equity in SiYi and one seat on SiYi’s board. The illicit drug testing membranes will continue to be manufactured and controlled by SBL.
chinese approval, page-66
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)